C-MER MEDICAL (03309) Sells 55% Stake in Apollo to Mingda Eyewear

Stock News12-17

On December 17, 2025, C-MER MEDICAL (03309) announced that it had entered into a deed with Mingda Eyewear. Under the agreement, the company agreed to transfer the sale shares back to Mingda Eyewear, representing 55% of Apollo's total issued share capital.

The transaction consideration involves Mingda Eyewear canceling and returning RMB 50.49 million in bonds previously issued by the company, thereby releasing C-MER MEDICAL from all obligations under the bonds. Upon completion, Apollo will cease to be a non-wholly owned subsidiary of the company, and C-MER MEDICAL will no longer hold any equity interest in Apollo.

The company stated that the group has implemented several strategic initiatives, including focusing on ophthalmic services in Hong Kong and mainland China, as well as dental and medical services in Shenzhen. The sale aligns with the group's strategy to optimize internal resource allocation.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment